Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Given camera pill

This article was originally published in The Gray Sheet

Executive Summary

Given Imaging's swallowable capsule for visualizing the inside of the small intestine to detect polyps, cancer or causes of bleeding gains FDA market go-ahead Aug. 1 via agency's 510(k) de novo process. The diagnostic imaging system is intended for use in conjunction with other endoscopic or radiological examinations. The capsule incorporates a small camera, lights, image transmitter and eight-hour battery (1"The Gray Sheet" July 30, 2001, p. 14)

You may also be interested in...



Given M2A Camera Pill Suspected Blood Indicator Gains 510(k) Clearance

Given Imaging will upgrade the RAPID software on its M2A camera pill computer workstation within the next 60 days for all U.S. customers with systems under warranty or service contract

Given M2A Camera Pill Suspected Blood Indicator Gains 510(k) Clearance

Given Imaging will upgrade the RAPID software on its M2A camera pill computer workstation within the next 60 days for all U.S. customers with systems under warranty or service contract

Given Plans Software Upgrade On Camera Pill Workstation In Early 2003

Given Imaging is looking to upgrade the software on the entire installed base of its Given M2A camera pill computer workstations in the U.S. in the beginning of 2003

Related Content

UsernamePublicRestriction

Register

OM006664

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel